Search

Search Constraints

You searched for: Author/Creator Venter, Amour

Search Results

1. Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients. (27th January 2015)

2. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Issue 9979 (2nd May 2015)

3. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Issue 1 (January 2017)